 | • レポートコード：MRC2Q12-16800 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、最小残存疾患（MRD）動的モニターのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 最小残存疾患（MRD）動的モニターのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 最小残存疾患（MRD）動的モニターの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 最小残存疾患（MRD）動的モニターのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの最小残存疾患（MRD）動的モニターの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の最小残存疾患（MRD）動的モニターの売上および2028年までの予測に焦点を当てています。 最小残存疾患（MRD）動的モニターのグローバル主要企業には、BGI Genomics Co.,Ltd.、OrigiMed、Burning Rock Biotech、Predicine、Genecast、3D Medicines、Gene+、Geneseeq、Tongshu Biotechnology、Berry Oncologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 最小残存疾患（MRD）動的モニター市場は、タイプとアプリケーションによって区分されます。世界の最小残存疾患（MRD）動的モニター市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 血液腫瘍MRDダイナミックモニタ、固形腫瘍MRDダイナミックモニタ 【アプリケーション別セグメント】 補助療法検査、予後判定、術後再発判定、免疫療法効果判定、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 最小残存疾患（MRD）動的モニター製品概要 - タイプ別市場（血液腫瘍MRDダイナミックモニタ、固形腫瘍MRDダイナミックモニタ） - アプリケーション別市場（補助療法検査、予後判定、術後再発判定、免疫療法効果判定、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の最小残存疾患（MRD）動的モニター販売量予測2017-2028 - 世界の最小残存疾患（MRD）動的モニター売上予測2017-2028 - 最小残存疾患（MRD）動的モニターの地域別販売量 - 最小残存疾患（MRD）動的モニターの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別最小残存疾患（MRD）動的モニター販売量 - 主要メーカー別最小残存疾患（MRD）動的モニター売上 - 主要メーカー別最小残存疾患（MRD）動的モニター価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（血液腫瘍MRDダイナミックモニタ、固形腫瘍MRDダイナミックモニタ） - 最小残存疾患（MRD）動的モニターのタイプ別販売量 - 最小残存疾患（MRD）動的モニターのタイプ別売上 - 最小残存疾患（MRD）動的モニターのタイプ別価格 ・アプリケーション別市場規模（補助療法検査、予後判定、術後再発判定、免疫療法効果判定、その他） - 最小残存疾患（MRD）動的モニターのアプリケーション別販売量 - 最小残存疾患（MRD）動的モニターのアプリケーション別売上 - 最小残存疾患（MRD）動的モニターのアプリケーション別価格 ・北米市場 - 北米の最小残存疾患（MRD）動的モニター市場規模（タイプ別、アプリケーション別） - 主要国別の最小残存疾患（MRD）動的モニター市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの最小残存疾患（MRD）動的モニター市場規模（タイプ別、アプリケーション別） - 主要国別の最小残存疾患（MRD）動的モニター市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の最小残存疾患（MRD）動的モニター市場規模（タイプ別、アプリケーション別） - 主要国別の最小残存疾患（MRD）動的モニター市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の最小残存疾患（MRD）動的モニター市場規模（タイプ別、アプリケーション別） - 主要国別の最小残存疾患（MRD）動的モニター市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの最小残存疾患（MRD）動的モニター市場規模（タイプ別、アプリケーション別） - 主要国別の最小残存疾患（MRD）動的モニター市場規模（トルコ、サウジアラビア） ・企業情報 BGI Genomics Co.,Ltd.、OrigiMed、Burning Rock Biotech、Predicine、Genecast、3D Medicines、Gene+、Geneseeq、Tongshu Biotechnology、Berry Oncology ・産業チェーン及び販売チャネル分析 - 最小残存疾患（MRD）動的モニターの産業チェーン分析 - 最小残存疾患（MRD）動的モニターの原材料 - 最小残存疾患（MRD）動的モニターの生産プロセス - 最小残存疾患（MRD）動的モニターの販売及びマーケティング - 最小残存疾患（MRD）動的モニターの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 最小残存疾患（MRD）動的モニターの産業動向 - 最小残存疾患（MRD）動的モニターのマーケットドライバー - 最小残存疾患（MRD）動的モニターの課題 - 最小残存疾患（MRD）動的モニターの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Minimal Residual Disease (MRD) Dynamic Monitor estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Minimal Residual Disease (MRD) Dynamic Monitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Minimal Residual Disease (MRD) Dynamic Monitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Minimal Residual Disease (MRD) Dynamic Monitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Minimal Residual Disease (MRD) Dynamic Monitor include BGI Genomics Co.,Ltd., OrigiMed, Burning Rock Biotech, Predicine, Genecast, 3D Medicines, Gene+, Geneseeq and Tongshu Biotechnology, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Minimal Residual Disease (MRD) Dynamic Monitor companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Minimal Residual Disease (MRD) Dynamic Monitor market. Further, it explains the major drivers and regional dynamics of the global Minimal Residual Disease (MRD) Dynamic Monitor market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
BGI Genomics Co.,Ltd.
OrigiMed
Burning Rock Biotech
Predicine
Genecast
3D Medicines
Gene+
Geneseeq
Tongshu Biotechnology
Berry Oncology
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Minimal Residual Disease (MRD) Dynamic Monitor Segment by Type
Blood Tumor MRD Dynamic Monitor
Solid Ttumor MRD Dynamic Monitor
Minimal Residual Disease (MRD) Dynamic Monitor Segment by Application
Adjuvant Therapy Testing
Prognostic Assessment
Postoperative Recurrence Detection
Immunotherapy Efficacy Testing
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Minimal Residual Disease (MRD) Dynamic Monitor market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Minimal Residual Disease (MRD) Dynamic Monitor market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Minimal Residual Disease (MRD) Dynamic Monitor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Minimal Residual Disease (MRD) Dynamic Monitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Minimal Residual Disease (MRD) Dynamic Monitor revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Minimal Residual Disease (MRD) Dynamic Monitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Minimal Residual Disease (MRD) Dynamic Monitor revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BGI Genomics Co.,Ltd., OrigiMed, Burning Rock Biotech, Predicine, Genecast, 3D Medicines, Gene+, Geneseeq and Tongshu Biotechnology, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Minimal Residual Disease (MRD) Dynamic Monitor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Minimal Residual Disease (MRD) Dynamic Monitor companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Minimal Residual Disease (MRD) Dynamic Monitor revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Tumor MRD Dynamic Monitor
1.2.3 Solid Ttumor MRD Dynamic Monitor
1.3 Market by Application
1.3.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adjuvant Therapy Testing
1.3.3 Prognostic Assessment
1.3.4 Postoperative Recurrence Detection
1.3.5 Immunotherapy Efficacy Testing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Perspective (2017-2028)
2.2 Minimal Residual Disease (MRD) Dynamic Monitor Growth Trends by Region
2.2.1 Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Minimal Residual Disease (MRD) Dynamic Monitor Historic Market Size by Region (2017-2022)
2.2.3 Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Region (2023-2028)
2.3 Minimal Residual Disease (MRD) Dynamic Monitor Market Dynamics
2.3.1 Minimal Residual Disease (MRD) Dynamic Monitor Industry Trends
2.3.2 Minimal Residual Disease (MRD) Dynamic Monitor Market Drivers
2.3.3 Minimal Residual Disease (MRD) Dynamic Monitor Market Challenges
2.3.4 Minimal Residual Disease (MRD) Dynamic Monitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Minimal Residual Disease (MRD) Dynamic Monitor Players by Revenue
3.1.1 Global Top Minimal Residual Disease (MRD) Dynamic Monitor Players by Revenue (2017-2022)
3.1.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue Market Share by Players (2017-2022)
3.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Minimal Residual Disease (MRD) Dynamic Monitor Revenue
3.4 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Concentration Ratio
3.4.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Minimal Residual Disease (MRD) Dynamic Monitor Revenue in 2021
3.5 Minimal Residual Disease (MRD) Dynamic Monitor Key Players Head office and Area Served
3.6 Key Players Minimal Residual Disease (MRD) Dynamic Monitor Product Solution and Service
3.7 Date of Enter into Minimal Residual Disease (MRD) Dynamic Monitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Minimal Residual Disease (MRD) Dynamic Monitor Breakdown Data by Type
4.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Historic Market Size by Type (2017-2022)
4.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Type (2023-2028)
5 Minimal Residual Disease (MRD) Dynamic Monitor Breakdown Data by Application
5.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Historic Market Size by Application (2017-2022)
5.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
6.2 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type
6.2.1 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2017-2022)
6.2.2 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2023-2028)
6.2.3 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Type (2017-2028)
6.3 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application
6.3.1 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2017-2022)
6.3.2 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2023-2028)
6.3.3 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Application (2017-2028)
6.4 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country
6.4.1 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
6.4.2 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
7.2 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type
7.2.1 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2017-2022)
7.2.2 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2023-2028)
7.2.3 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Type (2017-2028)
7.3 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application
7.3.1 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2017-2022)
7.3.2 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2023-2028)
7.3.3 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Application (2017-2028)
7.4 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country
7.4.1 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
7.4.2 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
8.2 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type
8.2.1 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Type (2017-2028)
8.3 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application
8.3.1 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Application (2017-2028)
8.4 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region
8.4.1 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
9.2 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type
9.2.1 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2017-2022)
9.2.2 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2023-2028)
9.2.3 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Type (2017-2028)
9.3 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application
9.3.1 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2017-2022)
9.3.2 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2023-2028)
9.3.3 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Application (2017-2028)
9.4 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country
9.4.1 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
9.4.2 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
10.2 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type
10.2.1 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Type (2017-2028)
10.3 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application
10.3.1 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Application (2017-2028)
10.4 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country
10.4.1 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BGI Genomics Co.,Ltd.
11.1.1 BGI Genomics Co.,Ltd. Company Details
11.1.2 BGI Genomics Co.,Ltd. Business Overview
11.1.3 BGI Genomics Co.,Ltd. Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.1.4 BGI Genomics Co.,Ltd. Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.1.5 BGI Genomics Co.,Ltd. Recent Developments
11.2 OrigiMed
11.2.1 OrigiMed Company Details
11.2.2 OrigiMed Business Overview
11.2.3 OrigiMed Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.2.4 OrigiMed Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.2.5 OrigiMed Recent Developments
11.3 Burning Rock Biotech
11.3.1 Burning Rock Biotech Company Details
11.3.2 Burning Rock Biotech Business Overview
11.3.3 Burning Rock Biotech Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.3.4 Burning Rock Biotech Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.3.5 Burning Rock Biotech Recent Developments
11.4 Predicine
11.4.1 Predicine Company Details
11.4.2 Predicine Business Overview
11.4.3 Predicine Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.4.4 Predicine Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.4.5 Predicine Recent Developments
11.5 Genecast
11.5.1 Genecast Company Details
11.5.2 Genecast Business Overview
11.5.3 Genecast Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.5.4 Genecast Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.5.5 Genecast Recent Developments
11.6 3D Medicines
11.6.1 3D Medicines Company Details
11.6.2 3D Medicines Business Overview
11.6.3 3D Medicines Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.6.4 3D Medicines Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.6.5 3D Medicines Recent Developments
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.7.4 Gene+ Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.7.5 Gene+ Recent Developments
11.8 Geneseeq
11.8.1 Geneseeq Company Details
11.8.2 Geneseeq Business Overview
11.8.3 Geneseeq Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.8.4 Geneseeq Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.8.5 Geneseeq Recent Developments
11.9 Tongshu Biotechnology
11.9.1 Tongshu Biotechnology Company Details
11.9.2 Tongshu Biotechnology Business Overview
11.9.3 Tongshu Biotechnology Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.9.4 Tongshu Biotechnology Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.9.5 Tongshu Biotechnology Recent Developments
11.10 Berry Oncology
11.10.1 Berry Oncology Company Details
11.10.2 Berry Oncology Business Overview
11.10.3 Berry Oncology Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.10.4 Berry Oncology Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.10.5 Berry Oncology Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer